SUBSCRIBE
SUBSCRIBE
News   FDA

Actelion Ltd.'s (JOBS) Tracleer Gets US Approval for Wider Use

August 10, 2009 | 
1 min read
Bookmark and Share

Reuters -- Europe's biggest biotech company Actelion Ltd said on Monday its Tracleer drug had been granted approval for mildly symptomatic pulmonary arterial hypertension (PAH).
FDA Approvals
MORE ON THIS TOPIC
Overcome crises with the patience of a visionary leader. Business team surfing sea waves with paper boats vector
Cancer
RevMed’s Rasonque gets a subtype data asterisk, but analysts remain bullish
October 12, 2026
 · 
2 min read
 · 
Michael Gibney
3D Yellow triangle warning sign symbol on yellow background. Emergency alert, and caution. Illustration with copy space
Drug Development
Newron reveals 5 deaths in late-stage schizophrenia program as FDA maintains hold
October 8, 2026
 · 
2 min read
 · 
Gabrielle Masson
Vintage white spiral clock dial with roman numerals. Concept of Infinite time, deadline, scheduling, time and space, past, present and future.
Manufacturing
FDA extends review of Novo’s hemophilia A drug, citing manufacturing issues
October 6, 2026
 · 
2 min read
 · 
Gabrielle Masson
Vector, flat illustration
Opinion
FDA must ensure American patients can access new and experimental drugs
October 5, 2026
 · 
7 min read
 · 
Houman David Hemmati